Patent details

EP3782994 Title: COMPOUNDS USEFUL AS KINASE INHIBITORS

Basic Information

Publication number:
EP3782994
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP201947249
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOUNDS USEFUL AS KINASE INHIBITORS
French Title of Invention:
COMPOSÉS UTILES COMME INHIBITEURS DE KINASE
German Title of Invention:
ALS KINASEINHIBITOREN GEEIGNETE VERBINDUNGEN
SPC Number:

Dates

Filing date:
16/12/2016
Grant date:
16/07/2025
EP Publication Date:
24/02/2021
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/07/2025
EP B1 Publication Date:
16/07/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/12/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/07/2025
 
 

Name:
Loxo Oncology, Inc.
Address:
Lilly Corporate Centre Indianapolis, Indiana 46285, United States (US)

Inventor

Name:
Guisot, Nicolas
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201522245
Priority Date:
16/12/2015
Priority Country:
United Kingdom (GB)

2

Priority Number:
201613945
Priority Date:
15/08/2016
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
C07D 405/14; C07D 405/04; C07D 405/06; C07D 405/08; C07D 403/04; C07D 413/06; C07D 417/04; C07D 401/04; C07D 401/06; C07D 231/14; C07D 231/38; A61P 35/00; A61P 35/02; A61P 37/02; A61K 31/4155; A61K 45/06;

Publication

European Patent Bulletin

Issue number:
202529
Publication date:
16/07/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages